FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948651405> ?p ?o ?g. }

• W2948651405 endingPage "788" @default.
• W2948651405 startingPage "788" @default.
• W2948651405 abstract "Cholesterol is a pivotal factor for cancer cells to entertain their relentless growth. In this case, we provide a novel strategy to inhibit tumor growth by simultaneous activation of liver-X-receptors and interference with Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1). Informed by a transcriptomic and subsequent gene set enrichment analysis, we demonstrate that inhibition of TRAP1 results in suppression of the cholesterol synthesis pathway in stem-like and established glioblastoma (GBM) cells by destabilizing the transcription factor SREBP2. Notably, TRAP1 inhibition induced cell death, which was rescued by cholesterol and mevalonate. Activation of liver X receptor (LXR) by a clinically validated LXR agonist, LXR623, along with the TRAP1 inhibitor, gamitrinib (GTPP), results in synergistic reduction of tumor growth and cell death induction in a broad range of solid tumors, which is rescued by exogenous cholesterol. The LXR agonist and TRAP1 inhibitor mediated cell death is regulated at the level of Bcl-2 family proteins with an elevation of pro-apoptotic Noxa. Silencing of Noxa and its effector BAK attenuates cell death mediated by the combination treatment of LXR agonists and TRAP1 inhibition. Combined inhibition of TRAP1 and LXR agonists elicits a synergistic activation of the integrated stress response with an increase in activating transcription factor 4 (ATF4) driven by protein kinase RNA-like endoplasmic reticulum kinase (PERK). Silencing of ATF4 attenuates the increase of Noxa by using the combination treatment. Lastly, we demonstrate in patient-derived xenografts that the combination treatment of LXR623 and gamitrinib reduces tumor growth more potent than each compound. Taken together, these results suggest that TRAP1 inhibition and simultaneous activation of LXR might be a potent novel treatment strategy for solid malignancies." @default.
• W2948651405 created "2019-06-14" @default.
• W2948651405 creator A5016632371 @default.
• W2948651405 creator A5019896041 @default.
• W2948651405 creator A5033751555 @default.
• W2948651405 creator A5045125797 @default.
• W2948651405 creator A5060786274 @default.
• W2948651405 creator A5081819949 @default.
• W2948651405 creator A5087856756 @default.
• W2948651405 date "2019-06-07" @default.
• W2948651405 modified "2023-10-02" @default.
• W2948651405 title "Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors" @default.
• W2948651405 cites W1897251005 @default.
• W2948651405 cites W2015644600 @default.
• W2948651405 cites W2035880310 @default.
• W2948651405 cites W2047367472 @default.
• W2948651405 cites W2093354991 @default.
• W2948651405 cites W2104450983 @default.
• W2948651405 cites W2116458487 @default.
• W2948651405 cites W2133717967 @default.
• W2948651405 cites W2140163306 @default.
• W2948651405 cites W2144310607 @default.
• W2948651405 cites W2157648818 @default.
• W2948651405 cites W2164601967 @default.
• W2948651405 cites W2177390620 @default.
• W2948651405 cites W2214858649 @default.
• W2948651405 cites W2333760797 @default.
• W2948651405 cites W2395626624 @default.
• W2948651405 cites W2522492952 @default.
• W2948651405 cites W2530768869 @default.
• W2948651405 cites W2586265133 @default.
• W2948651405 cites W2600787820 @default.
• W2948651405 cites W2616358207 @default.
• W2948651405 cites W2620939363 @default.
• W2948651405 cites W2738778921 @default.
• W2948651405 cites W2758067903 @default.
• W2948651405 cites W2765825833 @default.
• W2948651405 cites W2766229941 @default.
• W2948651405 cites W2774497455 @default.
• W2948651405 cites W2792873661 @default.
• W2948651405 cites W2806128074 @default.
• W2948651405 cites W2912834637 @default.
• W2948651405 cites W2925521234 @default.
• W2948651405 doi "https://doi.org/10.3390/cancers11060788" @default.
• W2948651405 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6627953" @default.
• W2948651405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31181660" @default.
• W2948651405 hasPublicationYear "2019" @default.
• W2948651405 type Work @default.
• W2948651405 sameAs 2948651405 @default.
• W2948651405 citedByCount "14" @default.
• W2948651405 countsByYear W29486514052020 @default.
• W2948651405 countsByYear W29486514052021 @default.
• W2948651405 countsByYear W29486514052022 @default.
• W2948651405 crossrefType "journal-article" @default.
• W2948651405 hasAuthorship W2948651405A5016632371 @default.
• W2948651405 hasAuthorship W2948651405A5019896041 @default.
• W2948651405 hasAuthorship W2948651405A5033751555 @default.
• W2948651405 hasAuthorship W2948651405A5045125797 @default.
• W2948651405 hasAuthorship W2948651405A5060786274 @default.
• W2948651405 hasAuthorship W2948651405A5081819949 @default.
• W2948651405 hasAuthorship W2948651405A5087856756 @default.
• W2948651405 hasBestOaLocation W29486514051 @default.
• W2948651405 hasConcept C104317684 @default.
• W2948651405 hasConcept C105580179 @default.
• W2948651405 hasConcept C119056186 @default.
• W2948651405 hasConcept C139447449 @default.
• W2948651405 hasConcept C149364088 @default.
• W2948651405 hasConcept C158617107 @default.
• W2948651405 hasConcept C166703698 @default.
• W2948651405 hasConcept C167400880 @default.
• W2948651405 hasConcept C170493617 @default.
• W2948651405 hasConcept C185592680 @default.
• W2948651405 hasConcept C190283241 @default.
• W2948651405 hasConcept C2779638656 @default.
• W2948651405 hasConcept C2780900454 @default.
• W2948651405 hasConcept C31573885 @default.
• W2948651405 hasConcept C502942594 @default.
• W2948651405 hasConcept C51785407 @default.
• W2948651405 hasConcept C55493867 @default.
• W2948651405 hasConcept C63932345 @default.
• W2948651405 hasConcept C67705224 @default.
• W2948651405 hasConcept C86339819 @default.
• W2948651405 hasConcept C86803240 @default.
• W2948651405 hasConcept C95444343 @default.
• W2948651405 hasConceptScore W2948651405C104317684 @default.
• W2948651405 hasConceptScore W2948651405C105580179 @default.
• W2948651405 hasConceptScore W2948651405C119056186 @default.
• W2948651405 hasConceptScore W2948651405C139447449 @default.
• W2948651405 hasConceptScore W2948651405C149364088 @default.
• W2948651405 hasConceptScore W2948651405C158617107 @default.
• W2948651405 hasConceptScore W2948651405C166703698 @default.
• W2948651405 hasConceptScore W2948651405C167400880 @default.
• W2948651405 hasConceptScore W2948651405C170493617 @default.
• W2948651405 hasConceptScore W2948651405C185592680 @default.
• W2948651405 hasConceptScore W2948651405C190283241 @default.
• W2948651405 hasConceptScore W2948651405C2779638656 @default.
• W2948651405 hasConceptScore W2948651405C2780900454 @default.
• W2948651405 hasConceptScore W2948651405C31573885 @default.

• next